Myriad Genetics (NASDAQ:MYGN) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS
Myriad Genetics (NASDAQ:MYGN - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.03). The company had revenue of $200.40 million during the quarter...